Surgery Partners Analyst Price Targets

Surgery Partners Inc

SGRYNASDAQ

$14.12

0.161.15%

$14.12

0.161.15%

Wall Street analyst price targets and consensus rating for Surgery Partners (SGRY).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$24Upside to Avg. PT+71.2%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 11, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$17→$19
Aug 11, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$20→$19
Aug 11, 2026	Cantor Fitzgerald	Sarah James	Maintained	Overweight	$18
Mar 5, 2026	TD Cowen	Ryan Langston	PT Cut	Buy	$28→$20
Mar 5, 2026	UBS	A.J. Rice	PT Cut	Buy	$29→$21
Mar 5, 2026	Mizuho	Ann Hynes	PT Cut	Outperform	$19→$17
Mar 4, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$31→$20
Mar 3, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$18→$14
Dec 18, 2025	Mizuho	Ann Hynes	PT Cut	Outperform	$22→$19
Nov 24, 2025	JP Morgan	Benjamin Rossi	PT Cut	Neutral	$27→$20
Nov 21, 2025	Barclays	Andrew Mok	PT Cut	Equal-Weight	$24→$18
Nov 17, 2025	Mizuho	Ann Hynes	PT Cut	Outperform	$28→$22
Nov 13, 2025	UBS	A.J. Rice	PT Cut	Buy	$34→$29
Nov 11, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$35→$31
Nov 11, 2025	Benchmark	Bill Sutherland	PT Cut	Buy	$35→$30
Oct 7, 2025	Cantor Fitzgerald	Sarah James	Maintained	Overweight	$36
Sep 18, 2025	JP Morgan	Benjamin Rossi	Assumes	Neutral	$27
May 27, 2025	Barclays	Andrew Mok	PT Cut	Equal-Weight	$25→$24
Apr 21, 2025	Benchmark	Bill Sutherland	Maintained	Buy	$35
Mar 25, 2025	RBC Capital	Ben Hendrix	Maintained	Outperform	$35